Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain-specific homeobox protein homolog (BSX) is an evolutionarily conserved homeodomain-containing transcription factor of the ANTP class, essential for the development and function of specific brain regions including the pineal gland, hypothalamic nuclei (notably the arcuate nucleus), telencephalic septum, and mammillary bodies[1][2][3][5][7]. In mice and zebrafish, BSX critically regulates neuronal differentiation, particularly of pineal photoreceptor cells and hypothalamic neurons that control key neuropeptides affecting energy balance (Agouti-related peptide, Neuropeptide Y). In the pineal gland, BSX is involved in regulating circadian gene expression and the development of melatonin-producing cells[1][3]. Mutations and altered expression patterns are associated with certain developmental syndromes (e.g., Jacobsen syndrome), but there is no evidence that BSX functions as a druggable target or established disease biomarker[5][6]. BSX acts upstream of or within the transcriptional regulatory networks defining neural tissue identity and differentiation[4][5][6].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain-specific homeobox protein homolog (BSX).